Alexey A. Matskevich
Technik-/Wissenschafts-/F&E-Leiter bei TheraMAB LLC
Aktive Positionen von Alexey A. Matskevich
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
TheraMAB LLC
 TheraMAB LLC BiotechnologyHealth Technology TheraMAB LLC develops immunotherapeutic monoclonal antibody. It focuses on the development of potential drug that, by its unique capacity to selectively modulate the activity of T-lymphocytes, may provide new treatment options for major diseases in the field of autoimmunity and cancer. The company was founded in August 2009 and is headquartered in Moscow, Russia. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Karriereverlauf von Alexey A. Matskevich
Ehemalige bekannte Positionen von Alexey A. Matskevich
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| University of Lausanne | Corporate Officer/Principal | 01.01.2009 | 01.01.2009 |
| University of Zurich | Corporate Officer/Principal | 01.01.2008 | 01.01.2008 |
| University of Strasbourg | Corporate Officer/Principal | 01.01.2005 | 01.01.2005 |
Ausbildung von Alexey A. Matskevich
| Moscow State University Lomonosov | Doctorate Degree |
Statistik
International
| Russland | 3 |
| Schweiz | 3 |
| Frankreich | 2 |
Operativ
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sektoral
| Consumer Services | 5 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
TheraMAB LLC
TheraMAB LLC BiotechnologyHealth Technology TheraMAB LLC develops immunotherapeutic monoclonal antibody. It focuses on the development of potential drug that, by its unique capacity to selectively modulate the activity of T-lymphocytes, may provide new treatment options for major diseases in the field of autoimmunity and cancer. The company was founded in August 2009 and is headquartered in Moscow, Russia. | Health Technology |
- Börse
- Insiders
- Alexey A. Matskevich
- Erfahrung
